Nanosphere Achieves CE-IVD Marks for Three Tests, Launches in Europe

The Northbrook, Ill.-based molecular diagnostics firm achieved CE-IVD marks for its Respiratory Virus Plus Nucleic Acid Test, its CYP 2C19 Nucleic Acid Test for clopidogrel metabolism, and its Warfarin Metabolism Nucleic Acid Test, all of which run on its Verigene platform.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.